VX1.STU VERTEX PHARMACEUTIC (VX1.SG)

Other Metals & Mining Stuttgart Exchange
- EUR
Market cap
-
P/E
33.8x
P/B
7.00x
ROE
21.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is VX1.STU undervalued?

Graham number

The Graham number of VERTEX PHARMACEUTIC (VX1.SG) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VERTEX PHARMACEUTIC (VX1.SG) fundamental analysis

No fundamental analysis for VERTEX PHARMACEUTIC (VX1.SG) yet.

VERTEX PHARMACEUTIC (VX1.SG) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VERTEX PHARMACEUTIC (VX1.SG)

There is no Profile data available for VX1.SG.

Full company profile